Pfizer's New Breast Cancer Drug Wins FDA Approval, Pioneering PROTAC Therapy
VEPPANU (vepdegestrant), co-developed by Pfizer and Arvinas, has received U.S. FDA approval for the treatment of specifi…
2 articles about 'FDA Approval'
VEPPANU (vepdegestrant), co-developed by Pfizer and Arvinas, has received U.S. FDA approval for the treatment of specifi…
BioticsAI CEO Robhy Bustami joined the Build Mode podcast to share how the company navigates FDA approval, secures fundi…